AIMEE ADAMS: Open Payments
NPI 1740620970 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,150 in 130 payments from 16 companies in 2025. Trend: 2023 $1,552 · 2024 $1,495 · 2025 $3,150
Food & beverage: $2,222Consulting: $760Education: $168
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $1,016 |
| E.R. Squibb & Sons, L.L.C. | 21 | $386 |
| LEO Pharma Inc. | 28 | $316 |
| ABBVIE INC. | 13 | $315 |
| Galderma Laboratories, L.P. | 25 | $300 |
| Novartis Pharmaceuticals Corporation | 10 | $214 |
| Janssen Biotech, Inc. | 5 | $146 |
| Amgen Inc. | 2 | $123 |
| Lilly USA, LLC | 4 | $77 |
| GENZYME CORPORATION | 2 | $58 |
Products named: Bimzelx, Sotyktu, NEMLUVIO, SKYRIZI, ADBRY, TREMFYA, COSENTYX, OTEZLA.
Industry payments across MI — which companies pay providers there.
